Coronary Artery Disease Clinical Trial
Official title:
Role of the Cardioflux Magnetocardiography System in Predicting Patient Outcomes With Coronary Artery Disease
This single-center clinical trial is designed to evaluate the CardioFlux magnetocardiograph diagnostic imaging system to predict major adverse cardiac events (MACE) in patients referred for evaluation for coronary artery disease.
This is a single-center, prospective, observational cohort trial to form a registry data set.
Patients presenting for cardiac stress testing utilizing Single Photon Emission Computed
Tomography (SPECT), cardiac CT angiography (CCTA), or cardiac catheterization will be offered
to enroll in the registry and provide informed consent to undergo imaging with a CardioFlux
magnetocardiography (MCG) prior to their procedure.
Multiple studies have shown that MCG accuracy is quite high in identifying patients with
symptomatic coronary artery disease. This difference is dramatic enough to prove superiority
over standard ECGs in diagnosis of vital ischemic and infarction parameters. Genetesis
presents a novel MCG analysis system called CardioFlux (CF). This modality takes less than
five minutes to complete, is radiation-free, and is an easy to operate system. This clinical
trial will enroll patients of all cardiac risk levels presenting for various modalities of
cardiac diagnostic testing to have CardioFlux scanning in addition to standard of care.
Results will be interpreted and compared to the immediate results of nuclear (SPECT) stress
testing, cardiac CT angiography, or cardiac catheterization.
Participants will be followed up at 30 days and 1 year via phone call or chart review. 30 day
and 1 year MACE will be recorded and correlated with initial CardioFlux MCG results.
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
and overall accuracy will be calculated of CardioFlux relative to the incidence of MACE, and
in comparison to the above diagnostic modalities.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Not yet recruiting |
NCT05366153 -
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
|
||
Recruiting |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Not yet recruiting |
NCT04647448 -
Multisensor Array for the Localisation of Coronary Artery Stenosis (MALCAS)
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT04562805 -
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
|
N/A | |
Recruiting |
NCT04310046 -
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
|
N/A | |
Active, not recruiting |
NCT04483791 -
DynamX Bioadaptor Hong Kong Registry
|
Phase 4 | |
Active, not recruiting |
NCT04677725 -
NEtwork to Control ATherothrombosis (NEAT Registry)
|
||
Completed |
NCT04375085 -
DESyne X2 Post Market Follow-up Study
|
N/A | |
Terminated |
NCT02528474 -
Comparison of Optical Coherence Tomographic Findings After Balloon Angioplasty With Two Different Paclitaxel-Coated Balloons for the Treatment of In-Stent Restenosis in Drug-Eluting Stents
|
N/A |